Transplant Genomics
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
Illumina, Devyser Diagnostics Ink IVD Development Agreement
The agreement will enable Sweden's Devyser to perform regulatory registrations of its NGS-based IVD tests on Illumina's MiSeqDx sequencer in the US and Europe.
Omixon and GenDx have independently developed nanopore-based HLA typing kits that are currently for research use only but eventually aimed for diagnostic use.
Immucor, Pirche Partner to Embed Epitope Matching Prediction Pipeline into Transplant Dx Software
An unspecified investment will give Immucor exclusive access to PIRCHE scores and embedded visualizations for HLA antibody analysis.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
Jun 25, 2019